+ Watch NPSP
on My Watchlist
A biopharmaceutical company focused on the development and commercialization of small molecule drugs and recombinant proteins.
NPSP has an illiquid balance sheet and a too high valuation compared to its sales potential. It is also loss making at least until 2011.
BATS data provided in real-time. NYSE, NASDAQ and NYSEMKT data delayed 15 minutes.
Real-Time prices provided by BATS. Market data provided by Interactive Data.
Company fundamental data provided by Morningstar. Earnings Estimates, Analyst Ratings and Key Statistics provided by Zacks.
SEC Filings and Insider Transactions provided by Edgar Online.
Powered and implemented by Interactive Data Managed Solutions. Terms & Conditions